肾移植患者中钙调神经磷酸酶抑制剂的药物基因组学未来发展 - Suppr | 超能文献

Future of the pharmacogenomics of calcineurin inhibitors in renal transplant patients.

作者信息

Zhu Huaijun, Ge Weihong

出版信息

Pharmacogenomics. 2011 Nov;12(11):1505-8. doi: 10.2217/pgs.11.129.

DOI:10.2217/pgs.11.129

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Future of the pharmacogenomics of calcineurin inhibitors in renal transplant patients.肾移植患者中钙调神经磷酸酶抑制剂的药物基因组学未来发展

Pharmacogenomics. 2011 Nov;12(11):1505-8. doi: 10.2217/pgs.11.129.

2

In vivo CYP3A activity is significantly lower in cyclosporine-treated as compared with tacrolimus-treated renal allograft recipients.与他克莫司治疗的肾移植受者相比，环孢素治疗的受者体内 CYP3A 活性显著降低。

Clin Pharmacol Ther. 2011 Sep;90(3):414-22. doi: 10.1038/clpt.2011.130. Epub 2011 Jul 13.

3

The CARI guidelines. Choice of calcineurin inhibitors in adult renal transplantation: effects on transplant outcomes.

Nephrology (Carlton). 2007 Feb;12 Suppl 1:S88-97. doi: 10.1111/j.1440-1797.2006.00734.x.

4

Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients.基因多态性对亚洲肾移植受者他克莫司给药有显著影响，但对环孢素给药无显著影响。

Transplant Proc. 2008 Jun;40(5):1690-5. doi: 10.1016/j.transproceed.2008.04.010.

5

A numerical scale comparison of renal transplant recipient experience with and opinions about calcineurin inhibitors.肾移植受者使用钙调神经磷酸酶抑制剂的体验及看法的数字量表比较

Nephron Clin Pract. 2004;97(2):c35-40. doi: 10.1159/000078398.

6

The CARI guidelines. Calcineurin inhibitors in paediatric renal transplantation.

Nephrology (Carlton). 2007 Feb;12 Suppl 1:S106-10. doi: 10.1111/j.1440-1797.2006.00736.x.

7

Induction of the unfolded protein response by calcineurin inhibitors: a double-edged sword in renal transplantation.钙调神经磷酸酶抑制剂诱导未折叠蛋白反应：肾移植中的双刃剑

Nephrol Dial Transplant. 2010 Jan;25(1):6-9. doi: 10.1093/ndt/gfp516. Epub 2009 Oct 1.

8

Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?在比较钙调神经磷酸酶抑制剂时，急性排斥反应是肾移植术后长期预后的关键预测指标吗？

Transplant Rev (Orlando). 2009 Jan;23(1):47-52. doi: 10.1016/j.trre.2008.08.005.

9

Pharmacogenetics of calcineurin inhibitors in renal transplantation.钙调磷酸酶抑制剂在肾移植中的遗传药理学。

Transplantation. 2009 Aug 15;88(3 Suppl):S62-7. doi: 10.1097/TP.0b013e3181afe9e7.

10

Arterial elasticity measurement in renal transplant patients under anticalcineurin immunosuppression.接受钙调神经磷酸酶抑制剂免疫抑制治疗的肾移植患者的动脉弹性测量

Transplant Proc. 2005 Nov;37(9):3788-90. doi: 10.1016/j.transproceed.2005.10.078.

引用本文的文献

1

CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment.肾移植受者的CYP3A5基因多态性：对他克莫司治疗的影响

Pharmgenomics Pers Med. 2018 Mar 7;11:23-33. doi: 10.2147/PGPM.S107710. eCollection 2018.

2

Association of CYP3A polymorphisms with the pharmacokinetics of cyclosporine A in early post-renal transplant recipients in China.中国肾移植术后早期受者 CYP3A 多态性与环孢素 A 药代动力学的相关性。

Acta Pharmacol Sin. 2012 Dec;33(12):1563-70. doi: 10.1038/aps.2012.136. Epub 2012 Oct 22.